Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ABBV-467 |
Synonyms | |
Therapy Description |
ABBV-467 inhibits MCL1, potentially leading increased apoptosis of Mcl1-expressing tumor cells (NCI Drug Dictionary) |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ABBV-467 | ABBV467|ABBV 467 | MCL1 Inhibitor 18 | ABBV-467 inhibits MCL1, potentially leading increased apoptosis of Mcl1-expressing tumor cells (NCI Drug Dictionary) |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04178902 | Phase I | ABBV-467 | A Study of the Safety and Tolerability of ABBV-467 in Adult Participants With Relapsed/Refractory Multiple Myeloma | Terminated | USA | ISR | FRA | ESP | AUS | 2 |